Skip to main content

ABCD Nationwide Degludec Audit Publications

Papers, abstracts, presentations, posters and webcasts emanating from the audit

Webcast

EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors.  Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit

 

Published papers

Colosimo S, Ruan Y,  Lumb A, Rea R, McDonald P, Bain SC, Abraham R, Gallen I, Ryder REJ, ABCD Nationwide Degludec Audit Contributors.  Exploratory outcomes of the use of insulin degludec in the real world: data from the Association of British Clinical Diabetologists nationwide degludec audit

Abstract Br J Diabetes 2024; 24(1):45-50

Full Paper Br J Diabetes 2024; 24(1):45-50

All contributors are listed 

 

Slides from presentations

 

Abstracts

ABCD Spring Meeting, London 2016: A Lumb, R Abraham, R Harper, SC Bain, R Rea, REJ Ryder, on behalf of the ABCD nationwide degludec audit contributors. Insulin degludec improves minor, severe and nocturnal hypoglycaemia in Type 1 diabetes: Association of British Clinical Diabetologists (ABCD) nationwide insulin degludec audit.

DUK Manchester 2017: AN Lumb, RD Rea, R Abraham, P McDonald, SC Bain and REJ Ryder. Effect on HbA1c of switching to insulin degludec from another basal insulin: the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetic Medicine 2017. 34 (Suppl 1): Abstract P182

EASD Lisbon 2017: AN Lumb, RD Rea, RR Abraham, P Macdonald, SC Bain, REJ Ryder on behalf of the ABCD nationwide degludec audit contributors. Effect of insulin degludec on HbA1c, weight and hypoglycaemia: data from the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit. Diabetologia 2017, Vol.60 Supplement1: Abstract 669

ADA Orlando 2018: AN. Lumb, Ian W. Gallen, A Bickerton, RR. Abraham, SC. Bain, R Harper, RE Ryder and ABCD Nationwide Degludec Audit Contributors. Use of Insulin Degludec in Type 1 Diabetes Clinical Practice in the U.K.—General Practice Data from Two English Regions and Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Degludec Audit. Diabetes 2018 Jul; 67 (Supplement 1): 2291-PUB. 

Posters 

ABCD Manchester, Spring 2016

EASD Lisbon 2017

 

The ABCD nationwide insulin degludec audit is an independent audit supported by an unrestricted grant from Novo Nordisk